ABVC BioPharma, Inc. (ABVC) P/E Ratio History
Deep ValueTrading at -3.9x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2004–2015
Loading P/E history...
P/E Ratio Analysis
As of June 29, 2026, ABVC BioPharma, Inc. (ABVC) trades at a price-to-earnings ratio of -3.9x, with a stock price of $1.53 and trailing twelve-month earnings per share of $-0.37.
The current P/E is 100% below its 5-year average of 3106.7x. Over the past five years, ABVC's P/E has ranged from a low of 1056.4x to a high of 7643.3x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.0x, ABVC trades at a 117% discount to its sector peers. The sector includes 231 companies with P/E ratios ranging from 0.0x to 191.4x.
Relative to the broader market, ABVC trades at a notable discount to the S&P 500 median P/E of 25.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ABVC DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
ABVC Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
ABVC P/E vs Peers
Neuroscience and Psychiatry Therapies peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $2B | 7.1Lowest | 0.69 | +817%Best | |
| $32B | 24.4 | 0.60Best | +5% | |
| $15B | 34.5 | 1.08 | +21% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
ABVC Historical P/E Data (2004–2015)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2015 Q1 | - | $1146.50 | $0.15 | 7643.3x | +146% |
| FY2005 Q2 | - | $501091.25 | $474.32 | 1056.4x | -66% |
| FY2005 Q1 | - | $546645.00 | $243.02 | 2249.4x | -28% |
| FY2004 Q4 | Dec 31 2004 | $364430.00 | $246.63 | 1477.6x | -52% |
Average P/E for displayed period: 3106.7x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
22+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ABVC — Frequently Asked Questions
Quick answers to the most common questions about buying ABVC stock.
What is ABVC's P/E ratio?
ABVC BioPharma, Inc. (ABVC) trailing twelve-month P/E ratio is -3.9x, based on TTM diluted EPS of $-0.37. The 5-year average P/E is 3106.7x and the historical range spans 1056.4x to 7643.3x.
Is ABVC stock overvalued or undervalued?
ABVC trades at -3.9x P/E, below its 5-year average of 3106.7x. At the 0th percentile of its historical range (1056.4x–7643.3x), the stock is priced at a discount to its own history.
Is ABVC stock expensive?
No, ABVC is not expensive on a historical basis. The current P/E of -3.9x is below the 5-year average of 3106.7x and sits at the 0th percentile of its valuation range.
What is ABVC's historical P/E range?
Over the past 5 years, ABVC's P/E ratio has ranged from 1056.4x to 7643.3x, with a median of 2249.4x and an average of 3106.7x. The current P/E of -3.9x places the stock at the 0th percentile of this range. Full historical data spans 2004–2015.
How does ABVC's P/E compare to the S&P 500?
ABVC trades at -3.9x P/E versus the S&P 500 median of 25.3x. The 115% discount to the market suggests lower growth expectations or perceived higher risk.
How does ABVC's valuation compare to Healthcare peers?
ABVC BioPharma, Inc. P/E of -3.9x compares to the Healthcare sector median of 23.0x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is ABVC's PEG ratio?
ABVC PEG ratio is N/A, based on a P/E of -3.9x and EPS growth of 7.1%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is ABVC's earnings yield?
ABVC earnings yield is N/A, the inverse of its -3.9x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.